Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 43, Issue 2, Pages 342-353
Publisher
Springer Science and Business Media LLC
Online
2021-11-22
DOI
10.1038/s41401-021-00788-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Panax notoginseng preparations as adjuvant therapy for diabetic kidney disease: a systematic review and meta-analysis
- (2020) Xiuge Tang et al. PHARMACEUTICAL BIOLOGY
- Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes
- (2020) Xiao Wei et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis
- (2019) Ping Zhou et al. Cells
- Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin-induced diabetic rats
- (2019) Changxia Dong et al. Acta Cirurgica Brasileira
- Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions
- (2019) Salisa Pintusophon et al. ACTA PHARMACOLOGICA SINICA
- From podocyte biology to novel cures for glomerular disease
- (2019) Elena Torban et al. KIDNEY INTERNATIONAL
- Ginsenoside-Rb1 Improved Diabetic Cardiomyopathy through Regulating Calcium Signaling by Alleviating Protein O-GlcNAcylation
- (2019) Linhui Qin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Ginsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway
- (2019) Fengwei Nan et al. MOLECULAR AND CELLULAR PROBES
- The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation
- (2018) Jun He et al. ACTA PHARMACOLOGICA SINICA
- Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5- c ]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase
- (2018) Isidro Crespo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice
- (2018) Wu Song et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity
- (2018) Manoj Paul et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in Fufang Xueshuantong Capsule
- (2017) Huan-huan Pang et al. Journal of Zhejiang University-SCIENCE B
- Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury
- (2017) Yoshihiro Ito et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury
- (2017) Heba El Gamal et al. Biomed Research International
- Diabetes and Kidney Disease: Role of Oxidative Stress
- (2016) Jay C. Jha et al. ANTIOXIDANTS & REDOX SIGNALING
- Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats
- (2015) Yue-guang Du et al. Chinese Journal of Integrative Medicine
- Oxidative stress in chronic vascular disease: From prediction to prevention
- (2015) Francesca Santilli et al. VASCULAR PHARMACOLOGY
- Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells
- (2015) Kaori Yama et al. Redox Biology
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neurop
- (2012) N. Hotta et al. DIABETIC MEDICINE
- Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model
- (2012) Qian Zhang et al. Journal of Natural Medicines
- Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy
- (2012) E. Jennifer Weil et al. KIDNEY INTERNATIONAL
- Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
- (2012) Wai Ho Tang et al. Frontiers in Pharmacology
- Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders
- (2011) Satish K. Srivastava et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Effects of panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus
- (2011) Qing-nian Tu et al. Chinese Journal of Integrative Medicine
- Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components
- (2010) Chang-yong Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Saponins Isolated from the Root of Panax notoginseng Showed Significant Anti-Diabetic Effects in KK-Ay Mice
- (2008) Zhong-Hua Chen et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Aldose Reductase Genotypes and Cardiorenal Complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients
- (2008) W.-Y. So et al. DIABETES CARE
- Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes
- (2008) Wenbin Shang et al. JOURNAL OF ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now